Impact of ultrasound limitation to assess aortitis in patients with giant cell arteritis : comparative study with FDG-PET/CT
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ..
OBJECTIVE: To determine the impact of ultrasound (US) intrinsic limitation to assess aortitis versus FDG-PET/CT in patients with US-proven giant cell arteritis (GCA) and to identify factors associated with aortic involvement.
METHODS: Retrospective observational study of patients referred to US fast-track clinics at two academic centres over a 4-year period. Only patients with GCA confirmed by US were included. Temporal arteries (TA) and extracranial arteries US were performed at baseline. FDG-PET/CT was performed according to clinician's criteria. An FDG artery uptake at the aorta higher than liver uptake was considered positive for aortitis.
RESULTS: Seventy-two of 186 patients with US-proven GCA underwent an FDG-PET/CT; 29 (40.3%) had a positive FDG-PET/CT and 24 (33.3%) presented aortitis. Only 6 (20.7%) patients with positive FDG-PET/CT had negative US findings of large vessel (LV)-GCA. Among patients with aortitis in FDG-PET/CT, only two (8.3%) had negative US findings of LV-GCA. Patients with aortitis were younger (68.9 vs 81;p<0.001), more frequently females (79.2% vs 39.6%;p=0.002) and had higher platelets count (413.4 vs 311.1;p=0014). Patients with aortitis presented positive TA US less frequently (41.7% vs 83.3%;p<0.001), but more LV US involvement (91.7% vs 41.7%; p<0.001) versus patients without aortitis. None of the patients with aortitis exhibited visual symptoms (0% vs 31.2%;p=0.001).
CONCLUSIONS: FDG-PET/CT can detect aortitis in one out of every three patients with US-proven GCA. However, a negative US examination for LV-GCA suggests a low risk of aortitis. Younger and female GCA patients with thrombocytosis, absence of visual manifestations and LV-GCA on US may more frequently present aortitis by FDG-PET/CT.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:9 |
---|---|
Enthalten in: |
RMD open - 9(2023), 3 vom: 01. Aug. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Molina-Collada, Juan [VerfasserIn] |
---|
Links: |
---|
Themen: |
0Z5B2CJX4D |
---|
Anmerkungen: |
Date Completed 21.08.2023 Date Revised 23.08.2023 published: Print Citation Status MEDLINE |
---|
doi: |
10.1136/rmdopen-2023-003329 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM360966128 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM360966128 | ||
003 | DE-627 | ||
005 | 20231226084140.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2023 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1136/rmdopen-2023-003329 |2 doi | |
028 | 5 | 2 | |a pubmed24n1203.xml |
035 | |a (DE-627)NLM360966128 | ||
035 | |a (NLM)37597848 | ||
035 | |a (PII)e003329 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Molina-Collada, Juan |e verfasserin |4 aut | |
245 | 1 | 0 | |a Impact of ultrasound limitation to assess aortitis in patients with giant cell arteritis |b comparative study with FDG-PET/CT |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 21.08.2023 | ||
500 | |a Date Revised 23.08.2023 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. | ||
520 | |a OBJECTIVE: To determine the impact of ultrasound (US) intrinsic limitation to assess aortitis versus FDG-PET/CT in patients with US-proven giant cell arteritis (GCA) and to identify factors associated with aortic involvement | ||
520 | |a METHODS: Retrospective observational study of patients referred to US fast-track clinics at two academic centres over a 4-year period. Only patients with GCA confirmed by US were included. Temporal arteries (TA) and extracranial arteries US were performed at baseline. FDG-PET/CT was performed according to clinician's criteria. An FDG artery uptake at the aorta higher than liver uptake was considered positive for aortitis | ||
520 | |a RESULTS: Seventy-two of 186 patients with US-proven GCA underwent an FDG-PET/CT; 29 (40.3%) had a positive FDG-PET/CT and 24 (33.3%) presented aortitis. Only 6 (20.7%) patients with positive FDG-PET/CT had negative US findings of large vessel (LV)-GCA. Among patients with aortitis in FDG-PET/CT, only two (8.3%) had negative US findings of LV-GCA. Patients with aortitis were younger (68.9 vs 81;p<0.001), more frequently females (79.2% vs 39.6%;p=0.002) and had higher platelets count (413.4 vs 311.1;p=0014). Patients with aortitis presented positive TA US less frequently (41.7% vs 83.3%;p<0.001), but more LV US involvement (91.7% vs 41.7%; p<0.001) versus patients without aortitis. None of the patients with aortitis exhibited visual symptoms (0% vs 31.2%;p=0.001) | ||
520 | |a CONCLUSIONS: FDG-PET/CT can detect aortitis in one out of every three patients with US-proven GCA. However, a negative US examination for LV-GCA suggests a low risk of aortitis. Younger and female GCA patients with thrombocytosis, absence of visual manifestations and LV-GCA on US may more frequently present aortitis by FDG-PET/CT | ||
650 | 4 | |a Observational Study | |
650 | 4 | |a Journal Article | |
650 | 4 | |a giant cell arteritis | |
650 | 4 | |a systemic vasculitis | |
650 | 4 | |a ultrasonography | |
650 | 7 | |a Fluorodeoxyglucose F18 |2 NLM | |
650 | 7 | |a 0Z5B2CJX4D |2 NLM | |
700 | 1 | |a Castrejón, Isabel |e verfasserin |4 aut | |
700 | 1 | |a Monjo-Henry, Irene |e verfasserin |4 aut | |
700 | 1 | |a Fernández-Fernández, Elisa |e verfasserin |4 aut | |
700 | 1 | |a Torres Ortiz, Gabriela |e verfasserin |4 aut | |
700 | 1 | |a Martínez-Barrio, Julia |e verfasserin |4 aut | |
700 | 1 | |a Álvaro-Gracia, José María |e verfasserin |4 aut | |
700 | 1 | |a de Miguel, Eugenio |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t RMD open |d 2015 |g 9(2023), 3 vom: 01. Aug. |w (DE-627)NLM254089658 |x 2056-5933 |7 nnns |
773 | 1 | 8 | |g volume:9 |g year:2023 |g number:3 |g day:01 |g month:08 |
856 | 4 | 0 | |u http://dx.doi.org/10.1136/rmdopen-2023-003329 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 9 |j 2023 |e 3 |b 01 |c 08 |